DISTINCTION BETWEEN PLEURAL MESOTHELIOMA AND PULMONARY ADENOCARCINOMAUSING MOC31 IN AN ASBESTOS SPRAYER

Citation
Pj. Ryan et al., DISTINCTION BETWEEN PLEURAL MESOTHELIOMA AND PULMONARY ADENOCARCINOMAUSING MOC31 IN AN ASBESTOS SPRAYER, Respiratory medicine, 91(1), 1997, pp. 57-60
Citations number
10
Categorie Soggetti
Cardiac & Cardiovascular System","Respiratory System
Journal title
ISSN journal
09546111
Volume
91
Issue
1
Year of publication
1997
Pages
57 - 60
Database
ISI
SICI code
0954-6111(1997)91:1<57:DBPMAP>2.0.ZU;2-D
Abstract
Asbestos exposure may cause asbestosis, pleural plaques and benign ple ural disease, and may pre-dispose to malignant mesothelioma and other neoplasms. The occurrence to two primary tumours in the same patient i s rare, and the appearance oi a pleural mesothelioma and another lung tumour is exceptional. The present case report describes a patient who , by standard immunohistochemistry, was thought to have mesothelioma a t pleuro-pneumonectomy, and adenocarcinoma in the other lung at post-m ortem 5 months later. Subsequent investigation using the MOC31 antibod y demonstrated a single pathology of adenocarcinoma of the lung. The a dditional use of this antibody has important histopathogical and legal implications.